We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

Limited Evidence for Behavioural and Service Delivery Interventions in Childhood Epilepsy: Urgent Need for Robust Trials

MedXY Editorial Team•Dec 16, 2025•Neurology
behavioural interventionschildrenepilepsyservice delivery

Background

Epilepsy in childhood presents distinct challenges given its potential impact on cognitive development, psychological well-being, and social functioning. In the UK, prevalence rates illustrate a substantial burden: approximately 1 in 1000 children aged 0–4 years have epilepsy, while 1 in 200 of those aged 5–19 years are affected. Conventional antiepileptic pharmacotherapy remains central, yet adjunctive strategies—particularly service delivery innovations and behavioural therapies—are increasingly sought to improve both seizure control and quality of life.

Study Design

This Cochrane systematic review synthesised randomised controlled trials (RCTs) and quasi-RCTs evaluating service delivery, behavioural, and self-management interventions for children aged 18 years or under with epilepsy. Eligible interventions targeted either the children themselves, their parents/carers, or both. Primary outcome was seizure control (frequency or seizure freedom), while secondary outcomes included seizure severity, overall quality of life (QoL), psychological health parameters, medication usage, general health, social functioning, and adverse effects. Outcomes were classified as short-term (≤ six months) or long-term (> six months). Rigorous study selection, data extraction, and bias assessment were performed by multiple reviewers, and certainty of evidence was graded using GRADE.

Key Findings

Six studies (n=468 participants) met inclusion criteria: four behavioural studies (three psycho-behavioural, one mind–body) and two service delivery studies. No eligible self-management interventions were identified.

Psycho-behavioural Interventions

One study of systemic family therapy (104 participants) demonstrated a modest reduction in monthly seizure frequency at three months compared to usual care (mean difference [MD] –1.98; 95% confidence interval [CI] –3.84 to –0.12; low-certainty evidence). The two other behavioural RCTs (n=94) reported seizure frequency outcomes descriptively at various intervals, without clear statistical benefit. A manual-based psychosocial group intervention yielded minimal QoL change at three months (Pediatric QoL Inventory: MD –1.40; 95% CI –8.21 to 5.41, very low-certainty; Glasgow Epilepsy Outcome Scale: MD –0.33; 95% CI –5.68 to 5.02).

Mind–Body Intervention

Yoga was evaluated in one small RCT (n=20). Findings suggested uncertainty regarding improved seizure freedom at three months (MD 1.62; 95% CI 0.97 to 2.69; low-certainty). QoL was not assessed.

Service Delivery Interventions

A clinical pharmacist-led education programme for carers (n=71) failed to demonstrate conclusive benefits in seizure control or child QoL (seizure freedom MD 1.32; 95% CI 0.86 to 2.00; very low-certainty; caregiver-assessed QoL improvement MD 10.46; 95% CI 1.82 to 19.10, very low-certainty). A WeChat-based remote follow-up programme (n=162) measured anxiety and depression but did not evaluate seizure control or overall QoL.

Safety

Notably, no adverse events were reported in any of the included studies, although sample sizes and follow-up durations were limited.

Expert Commentary

The reviewed evidence highlights several limitations: small sample sizes, heterogeneity in interventions and outcomes, and generally high risks of performance and detection bias. The absence of self-management intervention trials is a significant gap, given the importance of patient empowerment in chronic disease management. Outcome measures varied considerably, making cross-study comparisons and meta-analysis impossible. The predominance of short-term follow-up further constrains our understanding of sustained intervention efficacy.

Clinically, the low to very low certainty of evidence should temper enthusiasm for these strategies until more robust data are available. Systemic family therapy shows modest promise in short-term seizure reduction, but conclusions are tentative. The potential role of mind–body practices such as yoga remains underexplored, and remote service delivery innovations may improve accessibility but require better patient-centred outcome data.

Conclusion

Current research on behavioural and service delivery interventions for children with epilepsy is insufficient to guide firm clinical recommendations. The limited but suggestive benefits observed warrant further exploration via well-powered, methodologically rigorous RCTs with standardised, clinically relevant outcome sets. Future trials should integrate both short- and long-term endpoints, include patient-reported outcomes, and strive for blinding where practical. Establishing a core outcome set for paediatric epilepsy will be vital to harmonise future research.

Funding and Trial Registration

The Cochrane review did not report specific funding sources for the included studies. Clinical trial identifiers were not listed. Given the methodological limitations, future research transparency, including preregistration and clear reporting, will be critical.

References

Fleeman N, Mayer J, Huang Y, Nevitt SJ, Panebianco M, Hill RA, Doherty AJ, Wilson N, Boland P, Clegg AJ, Bilsborough H, Williams EJ, Shaw EJ, Maden M, Kelly R, Marson AG. Service delivery, behavioural, and self-management interventions for children with epilepsy. Cochrane Database Syst Rev. 2025 Oct 22;10(10):CD015287. doi: 10.1002/14651858.CD015287.pub2. PMID: 41123096; PMCID: PMC12542328.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP RegistryA comprehensive cohort study from the EURAP registry reveals that antiseizure medication, especially polytherapy and certain monotherapies, increases the risk of poor fetal growth, underscoring the need for optimized treatment strategies duSep 5, 2026Bone Health Index: A Novel Fracture Risk Assessment in Pediatric Osteogenesis ImperfectaThe Bone Health Index (BHI), derived from metacarpal radiographs, predicts fracture risk more effectively than DXA in children with Osteogenesis Imperfecta, especially infants under five where DXA is limited.Sep 1, 2026Balancing Risks: Safety Profiles of Antiseizure Medications in Epilepsy Patients on Direct Oral AnticoagulantsThis study reveals distinct thromboembolic, bleeding, and mortality risks based on antiseizure medication selection in epilepsy patients receiving direct oral anticoagulants, highlighting the critical role of ASM choice on patient safety anAug 18, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Mapping the Brain’s Eloquence: A Probabilistic Approach to Electrocortical Stimulation in Epilepsy
This study develops a comprehensive probabilistic atlas of brain function using extraoperative electrocortical stimulation mapping in epilepsy patients, revealing distributed and variable language and motor cortical organization beyond trad
Jul 1, 2026
Neurocognitive Outcomes of In Utero Exposure to Antiseizure Medication: An Australian Cohort StudyAn Australian cohort study found that prenatal exposure to valproate, levetiracetam, topiramate, and carbamazepine was associated with poorer cognitive outcomes in children, while lamotrigine exposure was not.Jun 7, 2026
Rural-Urban Disparities in Epilepsy Outcomes in the United StatesA national U.S. study found that patients with epilepsy from rural counties had worse hospital outcomes, including higher mortality, more status epilepticus, longer stays, and less EEG use, highlighting access-related disparities.Jun 5, 2026